Globus Medical, Inc. reported preliminary unaudited sales results for Q4 and full year 2025, anticipating sales of $823.2 million and $2.936 billion respectively. The company showed growth in US Spine and Enabling Technologies, aiming for sustained growth in 2026 with a revenue guidance of $3.18 billion to $3.22 billion and non-GAAP earnings per share of $4.30 to $4.40. These unaudited results are subject to change, with final results to be announced on February 24, 2026. Globus Medical, founded in 2003, focuses on musculoskeletal solutions to enable healing for patients. Non-GAAP financial measures are used to supplement GAAP financial statements, providing insight into the company’s performance.

Read more at GlobeNewswire: Globus Medical Reports Preliminary Record Fourth Quarter